AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|
21.4 C
New York
Monday, October 26, 2026

Tag: science

Politicians Suddenly Care About Plane Crashes—Is That the Real Turbulence?

Well, well, well, another day, another midair collision near Reagan National Airport. It's almost as if mixing military and commercial aircraft in tightly controlled...

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Linical Celebrates 20 Years of Advancing Clinical Research and Patient Wellbeing

OSAKA, Japan, June 10, 2025 /PRNewswire/ -- Linical, a leader in clinical research services, is proud to celebrate its 20th anniversary — a milestone...

Akesis Biologics Launches MastGut: A Breakthrough Supplement That Uses DUSP10 Enzyme to Support Gut and Colorectal Health

SINGAPORE, June 10, 2025 /PRNewswire/ -- Akesis Biologics, a biotechnology spin-off from the National University of Singapore (NUS), has officially launched its flagship gut...

Innerbody Labs Testosterone Support Announces Official Website Update Featuring Natural Daily Supplement for Men’s Health and Vitality

Updated Product Page Now Highlights Daily Testosterone Support Formula for Adult Men Seeking Natural Energy, Vitality, and Wellness Backed by Research
Updated Product Page Now Highlights Daily Testosterone Support Formula for Adult Men Seeking Natural Energy, Vitality, and Wellness Backed by Research

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - including the novel drug olverembatinib (HQP1351), the investigational Bcl-2 inhibitor lisaftoclax (APG-2575), and the investigational EED inhibitor APG-5918 – will be featured in an oral presentation, multiple poster presentations and multiple online publications at the 2025 European Hematology Association (EHA) Annual Congress taking place in Milan, Italy, from June 12-15, 2025.

Reticlear Announces New Retina Clearing Formula Using the Eye Flow Ritual Hack

Natural Vision Support Supplement Now Highlights Daily Retina Health Routine Known as the Eye Flow Ritual Hack
Natural Vision Support Supplement Now Highlights Daily Retina Health Routine Known as the Eye Flow Ritual Hack

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025

First presentation of the Phase 4 XYLO switch study reports blood pressure reductions in patients with narcolepsy when switching from twice-nightly high- to low-sodium...

HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight

The overall HER2+ gastric cancer market is projected to grow, driven by increasing biomarker testing, better patient selection, and continued advancements in HER2-targeted ADCs,...

Media advisory – Minister Joly and Petrina Gentile to discuss the future of the Canadian auto industry at the 2025 Canada Automotive Summit

VAUGHAN, ON, June 9, 2025 /CNW/ - The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions,...

Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer

SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June...

Tarkett innovates circular recycling solution for Powerbond hybrid carpet

SOLON, Ohio, June 9, 2025 /PRNewswire/ -- On its path toward circularity, global flooring manufacturer Tarkett has found a new, circular solution for its...

Les Laboratoires nucléaires canadiens et l’Université d’Ottawa accélèrent la recherche sur le rayonnement à faible dose et font progresser la prochaine génération de scientifiques

Un nouveau partenariat renforce le leadership international du Canada dans la recherche sur le rayonnement à faible dose
Un nouveau partenariat renforce le leadership international du Canada dans la recherche sur le rayonnement à faible dose

Canadian Nuclear Laboratories and the University of Ottawa Accelerate Low Dose Radiation Research and Foster Next Generation of Scientists

New partnership furthers Canada’s international leadership in low dose radiation research
New partnership furthers Canada’s international leadership in low dose radiation research

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsScience